Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides, anti-OX40, anti-PD1 antibodies, and aptamers Proskurina AS, Ruzanova VS, Ritter GS, Efremov YR, Mustafin ZS, Lashin SA, Burakova EA, Fokina AA, Zatsepin TS, Stetsenko DA, Leplina OY, Ostanin AA, Chernykh ER, Bogachev SS J Biomed Res, 2023
2021
Experimental comparison of the in vivo efficacy of two novel anticancer therapies Ruzanova VS, Proskurina AS, Ritter GS, Efremov YR, Nikolin VP, Popova NA, Naprimerov VA, Dolgova EV, Potter EA, Kirikovich SS, Levites EV, Mustafin ZS, Lashin SA, Burakova EA, Stetsenko DA, Ostanin AA, Chernykh ER, Bogachev SS ANTICANCER RES, 2021, V. 41. N 7. P. 3371-3387
New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1 Dyrkheeva N.S., Filimonov A.S., Luzina O.A., Orlova K.A., Chernyshova I.A., Kornienko T.E., Malakhova A.A., Medvedev S.P., Zakharenko A.L., Ilina E.S., Anarbaev R.O., Naumenko K.N., Klabenkova K.V., Burakova E.A., Stetsenko D.A., Zakian S.M., Salakhutdinov N.F., Lavrik O.I. INT J MOL SCI, 2021, V. 22(21). P.11336.
2020
CpG олигонуклеотиды с модифицированными фосфатными группами индуцируют созревание миелоидных дендритных клеток человека in vitro Останин А.А., Леплина О.Ю., Буракова Е.А., Тыринова Т.В., Фокина А.А., Проскурина А.С., Богачев С.С., Стеценко Д.А., Черных Е.Р. Vavilov journal of genetics and breeding, 2020, Т. 24, № 6, С. 653-660
